Stay informed with the latest updates for the inheritable blood disorders community. Industry HEMLIBRA® Shows Prophylactic Efficacy in Hemophilia A Patients…Dec 5, 2017 NBDF & Community NHF Announces the 2017 NHF/Novo Nordisk Career Development Award Recipient…Dec 4, 2017 Advocacy & Legislative It's Not Too Late: Take Action on Tax ReformDec 4, 2017 Medical Partners Module Addresses Psychosocial Considerations in Children…Nov 29, 2017 NBDF & Community "Action to Hope" Study Open to Hemophilia CommunityNov 29, 2017 NBDF & Community Clinician Monographs Available through NHF Resource CenterNov 28, 2017 Industry FDA Grants Orphan Drug Designation for Rofecoxib, Pain…Nov 21, 2017 Industry First Patient Enrolled in ITI Trial Using Eloctate Nov 21, 2017 Medical FDA Approves Once-Weekly Subcutaneous Therapy for Hemophilia…Nov 16, 2017 Advocacy & Legislative Call to Action on Senate Tax PlanNov 16, 2017 Medical THSNA Summit Coming in March 2018Nov 15, 2017 Medical Psychosocial Needs of Aging Patients with Hemophilia the Focus of…Nov 13, 2017 Industry Alnylam Announces Successful Meeting with FDA on Fitusiran Nov 13, 2017 Medical NHF Awards Three Judith Graham Pool Postdoctoral Research FellowshipsNov 9, 2017 Medical New Educational Webinars for Healthcare Providers Outside HematologyNov 9, 2017 Pagination First page Previous page … Page 47 Page 48 Page 49 Page 50 Current page 51 Page 52 Page 53 Page 54 Page 55 … Next page Last page
!["Action to Hope" Study Open to Hemophilia Community](/sites/default/files/styles/event_teaser/public/image/dco-patient.jpg?itok=eKSZYBMj ""Action to Hope" Study Open to Hemophilia Community")
